Wattle Health - revenue for the 4 months ended Oct 2016 was 771,255 so if yearly assume $2.3m
Stock price at 22.5c with market cap of 26m is priced at 11.3 times revenue, compared to companies like Bal which trades at something like 1.6 times revenue and bkl which trades at something like 2.7 times revenue WHA looks more than fully valued for now until revenue increases dramatically.
- Forums
- ASX - By Stock
- WNX
- Ann: Wattle Health Australia Commences Trading on the ASX
Ann: Wattle Health Australia Commences Trading on the ASX, page-49
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WNX (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.0¢ |
Change
-0.001(3.23%) |
Mkt cap ! $38.69M |
Open | High | Low | Value | Volume |
3.0¢ | 3.1¢ | 3.0¢ | $19.79K | 649.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 210736 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.1¢ | 332497 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 210736 | 0.030 |
2 | 2348000 | 0.029 |
4 | 1223886 | 0.028 |
2 | 62053 | 0.027 |
4 | 733186 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.031 | 332497 | 1 |
0.032 | 1625000 | 3 |
0.033 | 1280000 | 2 |
0.034 | 500000 | 1 |
0.035 | 25538 | 3 |
Last trade - 13.55pm 15/07/2024 (20 minute delay) ? |
Featured News
WNX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online